23 July 1999
Consolidation in the UK pharmaceutical industry has forced the top three companies to review their property strategies, putting new emphasis on flexibility. Lucy Benyon looks at the challenges posed to the traditional property world by this industry
You must be logged in to continue
Register for free to finish this article.
Sign up now for the following benefits:
To access this article REGISTER NOW
Would you like print copies, app and digital replica access too? SUBSCRIBE for as little as £5 per week.